Novozymes
NZYM.VI
#720
Rank
$27.19 B
Marketcap
$58.98
Share price
0.74%
Change (1 day)
17.89%
Change (1 year)
Categories

P/E ratio for Novozymes (NZYM.VI)

P/E ratio as of March 2024 (TTM): 35.3

According to Novozymes's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 35.2817. At the end of 2022 the company had a P/E ratio of 27.1.

P/E ratio history for Novozymes from 2018 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202227.1-41.54%
202146.424.67%
202037.225.46%
201929.617.06%
201825.3

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.